From a disease indication to a ranked list of cell-type-grounded target hypotheses
Input a disease indication and tissue context. Receive a ranked list of cell populations driving the phenotype and, for each, a set of target gene candidates scored by expression specificity. Built on a foundation model trained on millions of single-cell profiles across human tissues and disease states.
How the platform is built
The platform is a four-layer system. Each layer addresses a distinct problem in single-cell-based target identification, from raw data harmonization to structured hypothesis output.
From raw scRNA-seq to harmonized embeddings
The data pipeline addresses three practical obstacles in building robust models from multi-source single-cell data: preprocessing variability, batch effects, and gene vocabulary differences across datasets.
Quality filtering, normalization (log1p counts), and gene selection per dataset. Standardized across all ingested sources regardless of the original protocol or sequencing depth.
Integration of data from different labs, donors, and platforms using harmonization methods that remove technical variation while preserving biological signal. A critical step given the diversity of the training corpus.
Each cell is encoded to a dense vector by the foundation model encoder. Embeddings are indexed for retrieval and periodically updated as the training corpus expands with new public data.
What discovery teams receive
The platform produces structured output designed for direct use by bioinformatics and discovery teams. Three components per query.
A ranked list of cell populations associated with the disease phenotype in the query tissue. Each population includes the cell-type annotation, a confidence score based on expression pattern overlap with disease signal, and cross-tissue prevalence data.
For each ranked cell population, a list of gene candidates with expression specificity scores. Specificity is computed across cell types and tissues, surfacing genes that are preferentially expressed in the disease-associated population and not broadly active across unrelated cell types.
For each target candidate, the output includes links to the source datasets where the expression evidence was observed, enabling discovery teams to trace each hypothesis to the underlying single-cell observations. No black box: every rank has an interpretable data anchor.
API access and research portal
The platform is available via API for integration into bioinformatics pipelines, and through a research portal UI for discovery teams who prefer an interactive query interface. Both access modes return the same structured output.
We are currently accepting early access requests from drug discovery teams and research collaborators. Access is reviewed by the team and granted on a rolling basis.
Request Access